Effects of high and low molecular weight chitosan on plasma cholesterol, glucose and adipocytokines in diabetic rats induced by streptozotocin and nicotinamide

Journal of Food and Drug Analysis

Volumn 20, Issue 3, 2012, Pages

  Chang, Hin Pang ^a   Yao, Hsien Tsung ^b   Chiang, Meng Tsan ^a  

^a NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adipocytokines; Chitosan; Diabetes; Insulin resistance; Molecular weight

Indexed keywords

ADIPOCYTOKINE; CHITOSAN; FRUCTOSAMINE; GLUCOSE; HIGH MOLECULAR CHITOSAN; LACTASE; LEPTIN; LOW MOLECULAR CHITOSAN; NICOTINAMIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SUCRASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE MODEL; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIVER; LIVER WEIGHT; MALE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

RATTUS;

EID: 84870949382     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.6227/jfda.2012200313     Document Type: Article

References (41)

1. Schinner, S., Scherbaum, W. A., Bornstein, S. R. and Barthel, A. 2005. Molecular echanisms of insulin resistance. Diabet. Med. 22: 674-682.
2. World Health Organization. 2008. Health topics, diabetes, fact sheet: diabetes. http://www.who.int/mediacentre/factsheets/fs312/en/index.html.
3. Walder, K., Filippis, A., Clark, S., Zimmet, P. and Collier, G. R. 1997. Leptin inhibits insulin binding in isolated rat adipocytes. J. Endocrinol. 155: R5-R7. (Pubitemid 27524068)
4. Samad, F. and Loskutoff, D. J. 1996. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol. Med. 2: 568-582. (Pubitemid 26353106)
5. Vaughan, D. E. 2005. PAI-1 and atherothrombosis. J. Thromb. Haemost. 3: 1879-1883. (Pubitemid 41716575)
6. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F. and Spiegelman, B. M. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271: 665-668. (Pubitemid 26052915)
7. Gallaher, C. M., Munion, J., Hesslink, R. Jr., Wise, J. and Gallaher, D. D. 2000. Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J. Nutr. 130: 2753-2759.
8. Yao, H. T. and Chiang, M. T. 2006. Effect of chitosan on plasma lipids, hepatic lipids, and fecal bile acid in hamsters. J. Food Drug Anal. 14: 183-189.
9. Liu, J., Zhang, J. and Xia, W. 2008. Hypocholesterolaemic effects of different chitosan samples in vitro and in vivo. Food Chem. 107: 419-425. (Pubitemid 47633876)
10. Yao, H. T., Huang, S. Y. and Chiang, M. T. 2008. A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. Food Chem. Toxicol. 46: 1525-1534.
11. Neyrinck, A. M., Bindels, L. B., De Backer, F., Pachikian, B. D., Cani, P. D. and Delzenne, N. M. 2009. Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. Int. Immunopharmacol. 9: 767-773.
12. Liu, S. H., Chang, Y. H. and Chiang, M. T. 2010. Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats. J. Agric. Food Chem. 58: 5795-5800.
13. LeHoux, J. G. and Grondin, F. 1993. Some effects of chitosan on liver function in the rat. Endocrinology 132: 1078-1084. (Pubitemid 23068621)
14. Kondo, Y., Nakatani, A., Hayashi, K. and Ito, M. 2000. Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice. Biol. Pharm. Bull. 23: 1458-1464. (Pubitemid 32016310)
15. Hayashi, K. and Ito, M. 2002. Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice. Biol. Pharm. Bull. 25: 188-192. (Pubitemid 39592102)
16. Lee, H. W., Park, Y. S., Choi, J. W., Yi, S. Y. and Shin, W. S. 2003. Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced noninsulin-dependent diabetes mellitus in rats. Biol. Pharm. Bull. 26: 1100-1103.
17. Masiello, P., Broca, C., Gross, R., Roye, M., Manteghetti, M. and Hillaire-Buys, D. et al. 1998. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47: 224-229. (Pubitemid 28079978)
18. Yao, H. T. and Chiang, M. T. 2002. Plasma lipoprotein cholesterol in rats fed a diet enriched in chitosan and cholesterol. J. Nutr. Sci. Vitaminol. 48: 379-383.
19. Vårum, K. M., Ottøy, M. H. and Smidsrød, O. 2001. Acid hydrolysis of chitosans. Carbohyd. Polym. 46: 89-98. (Pubitemid 32487092)
20. Wang, W., Bo, S. Q., Li, S. Q. and Qin, W. 1991. Determination of the Mark-Houwink equation for chitosans with different degrees of deacetylation. Int. J. Biol. Macromol. 13: 281-285.
21. Chen, R. H. and Hwa, H. D. 1996. Effect of molecular weight of chitosan with the same degree of deacetylation on the thermal, mechanical, and permeability properties of the prepared membrane. Carbohyd. Polym. 29: 353-358. (Pubitemid 126373974)
22. Baxter, A., Dillon, M., Taylor, K. D. and Roberts, G. A. 1992. Improved method for i.r. determination of the degree of N-acetylation of chitosan. Int. J. Biol. Macromol. 14: 166-169.
23. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. 1985. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. (Pubitemid 15018832)
24. Takehisa, F. and Suzuki, Y. 1990. Effect of guar gum and cholestyramine on plasma lipoprotein cholesterol in rats. J. Jpn. Soc. Nutr. Food Sci. 43: 269-274.
25. Folch, J., Lees, M. and Sloane Stanley, G. H. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
26. Carlson, S. E. and Goldfarb, S. 1977. A sensitive enzymatic method for determination of free and esterified tissue cholesterol. Clin. Chim. Acta. 79: 575-582. (Pubitemid 8170380)
27. Dahlqvist, A. 1968. Assay of intestinal disaccharidases. Anal. Biochem. 22: 99-107.
28. Hernández-González, S. O., González-Ortiz, M., Martínez-Abundis, E. et al. 2010. Chitosan improves insulin sensitivity as determined by the euglycemic-hyperinsulinemic clamp technique in obese subjects. Nutr. Res. 30: 392-395.
29. Matsuzawa, Y. 2006. The metabolic syndrome and adipocytokines. FEBS Lett. 580: 2917-2921. (Pubitemid 43729162)
30. Hotamisligil, G. S., Shargill, N. S. and Spiegelman, B. M. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91. (Pubitemid 23036092)
31. Bastard, J. P., Maachi, M. and Van-Nhieu, J. T. et al. 2002. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 87: 2084-2089. (Pubitemid 34521492)
32. Sobel, B. E., Woodcock-Mitchell, J., Schneider, D. J., Holt, R. E., Marutsuka, K. and Gold, H. 1998. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence. Circulation 97: 2213-2221. (Pubitemid 28265382)
33. Loskutoff, D. J., Ny, T., Sawdey, M. and Lawrence, D. 1986. Fibrinolytic system of cultured endothelial cells: regulation by plasminogen activator inhibitor. J. Cell. Biochem. 32: 273-280. (Pubitemid 17218673)
34. Chomiki, N., Henry, M., Alessi, M. C., Anfosso, F. and Juhan-Vague, I. 1994. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls. Thromb. Haemost. 72: 44-53. (Pubitemid 24202293)
35. Samad, F. and Loskutoff, D. J. 1996. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol. Med. 2: 568-582. (Pubitemid 26353106)
36. Samad, F., Uysal, K. T., Wiesbrock, S. M., Pandey, M., Hotamisligil, G. S. and Loskutoff, D. J. 1999. Tumor necrosis factor-α is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proc. Natl. Acad. Sci. 96: 6902-6907. (Pubitemid 29274982)
37. Newsholme, E. A. and Dimitriadis, G. 2001. Integration of biochemical and physiologic effects of insulin on glucose metabolism. Exp. Clin. Endocrinol. Diabetes 109: S122-S134. (Pubitemid 32577576)
38. Yu, A. S. and Keeffe, E. B. 2002. Nonalcoholic fatty liver disease. Rev. Gastroenterol. Disord. 2: 11-19. (Pubitemid 34467665)
39. Seppala-Lindroos, A., Vehkavaara, S., Hakkinen, A. M., Goto, T., Westerbacka, J., Sovijarvi, A., Halavaara, J. and Yki-Jarvinen, H. 2002. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol Metab. 87: 3023-3028. (Pubitemid 34816338)
40. Choi, Y. S., Cho, S. H., Kim, H. J. and Lee, H. J. 1998. Effects of soluble dietary fibers on lipid metabolism and activities of intestinal disaccharidases in rats. J. Nutr. Sci. Vitaminol. 44: 591-600.
41. Doi, K. 1995. Effect of konjac fiber (glucomannan) on glucose and lipids. Eur. J. Clin. Nutr. 49: S190-S197.